TP53 and breast carcinoma: For example, Yi et al. (2019) demonstrated that HDAC11 upregulation could suppress basal-like breast cancer cell invasion and metastasis; Wang et al. (2017) showed that HDAC11 inhibited p53 expression in pituitary tumor cells.